Clubfoot DNA Repository
1 other identifier
observational
379
1 country
1
Brief Summary
To build a DNA repository to enable participation in ongoing and future Clubfoot genetic linkage studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 22, 2008
CompletedFirst Posted
Study publicly available on registry
February 5, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 4, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 4, 2017
CompletedMay 9, 2017
May 1, 2017
9.3 years
January 22, 2008
May 5, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To identify a gene, or genes, that are associated with isolated clubfoot.
10 years
Secondary Outcomes (1)
New or improved ways to determine individuals and families at higher risk for clubfoot and development of new or improved ways to treat clubfoot.
10 years
Eligibility Criteria
Patients being treated at the participating facilities with a diagnosis of clubfoot, and their affected family members.
You may qualify if:
- For a family to be included in this study there should be at least one person in the family affected with Idiopathic Talipes Equinovarus (or clubfoot). If the person satisfies this criterion, then the affected person and his/her parents are included in the study. If there are other individuals in the family who are also affected (e.g. a cousin), then these individuals are also invited to participate in the study along with their parents, siblings and all other family members that link the two affected individuals (e.g. grandparents).
You may not qualify if:
- Inability to speak and read English or Spanish
- Should not have any other major birth defect (e.g. Heart defects, Downs Syndrome or cerebral palsy).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Texas Scottish Rite Hospital for Children
Dallas, Texas, 75219, United States
Related Links
Biospecimen
Each of the study participants (affected and non-affected individuals) will be asked to provide DNA from a blood sample. A 10cc sample of blood will be removed on 1 or 2 occasions by drawing blood from the arm or by finger stick by research staff. If the participant is a child who will be undergoing surgery, the blood sample will be collected at that time to eliminate additional stick. If collecting a blood sample is not possible we can also obtain DNA by collecting a saliva sample. This second technique does not give us as much DNA as we would get from blood. Therefore, if we get saliva samples, we might require more than one saliva sample over the course of the study.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan Rios, PhD
Texas Scottish Rite Hospital for Children
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff Scientist
Study Record Dates
First Submitted
January 22, 2008
First Posted
February 5, 2008
Study Start
January 1, 2008
Primary Completion
May 4, 2017
Study Completion
May 4, 2017
Last Updated
May 9, 2017
Record last verified: 2017-05